Comerica (CMA) PT Lowered to $40 at Piper Sandler
Get Alerts CMA Hot Sheet
Price: $88.67 --0%
Rating Summary:
6 Buy, 28 Hold, 7 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 17 | New: 18
Rating Summary:
6 Buy, 28 Hold, 7 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 17 | New: 18
Join SI Premium – FREE
Piper Sandler analyst Brett Rabatin lowered the price target on Comerica (NYSE: CMA) to $40.00 (from $44.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Canaccord Downgrades Botanix Pharmaceuticals Ltd (BOT:AU) to Hold
- Ballard Power Systems (BLDP) PT Lowered to $1.68 at Jefferies
- Zymeworks (ZYME) PT Raised to $35 at Truist Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share